Testing effectiveness (Phase 2)Study completedNCT02383498What this trial is testingQUILT-3.011 Phase 2 Yeast-Brachyury Vaccine ChordomaWho this might be right forChordoma NantCell, Inc. 24
Early research (Phase 1)Study completedNCT01924689What this trial is testingSafety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard TherapiesWho this might be right forSolid Tumor Malignancies BioMed Valley Discoveries, Inc 24
Testing effectiveness (Phase 2)Study completedNCT03110744What this trial is testingCDK4/6 Inhibition in Locally Advanced/Metastatic ChordomaWho this might be right forChordoma University Hospital Heidelberg 43
Testing effectiveness (Phase 2)UnknownNCT04042597What this trial is testingAnlotinib Hydrochloride Versus Imatinib Mesylate in Locally Advanced, Unresectable or Metastatic ChordomaWho this might be right forEffect of DrugsQuality of LifeChordoma+1 more Peking University People's Hospital 60
Testing effectiveness (Phase 2)Study completedNCT03623854What this trial is testingNivolumab and Relatlimab in Treating Participants With Advanced ChordomaWho this might be right forChordomaLocally Advanced ChordomaMetastatic Chordoma+1 more Jonsson Comprehensive Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT03083678What this trial is testingAfatinib in Locally Advanced and Metastatic ChordomaWho this might be right forChordoma Leiden University Medical Center 43
Early research (Phase 1)Ended earlyNCT05355753What this trial is testingAssess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null TumorsWho this might be right forSynovial SarcomaSoft Tissue Sarcoma C4 Therapeutics, Inc. 49
Testing effectiveness (Phase 2)Looking for participantsNCT06787664What this trial is testingBL-B01D1 in Patients With Locally Advanced or Metastatic ChordomaWho this might be right forChordoma Sichuan Baili Pharmaceutical Co., Ltd. 40